Tianshui Zhongxing Bio-technology Co.,Ltd.
Символ: 002772.SZ
SHZ
7.08
CNYПазарна цена днес
-737.4208
Съотношение P/E
6.7057
Коефициент PEG
2.78B
MRK Cap
- 0.04%
Доходност на DIV
Tianshui Zhongxing Bio-technology Co.,Ltd. (002772-SZ) финансови отчети
Баланс
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 7275.59 | 1323.5 | 1695.7 | 1858.6 | |||||||||||||
balance-sheet.row.short-term-investments | 1270.01 | 285 | 369.5 | 263.4 | |||||||||||||
balance-sheet.row.net-receivables | 164.79 | 28.3 | 80.9 | 21.6 | |||||||||||||
balance-sheet.row.inventory | 5047.14 | 1274.6 | 1255.5 | 1173.9 | |||||||||||||
balance-sheet.row.other-current-assets | 129.54 | 32.8 | 4.8 | 24.4 | |||||||||||||
balance-sheet.row.total-current-assets | 12617.05 | 2659.2 | 3036.9 | 3078.5 | |||||||||||||
balance-sheet.row.property-plant-equipment-net | 11878.82 | 2946.8 | 3074 | 3005.4 | |||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.intangible-assets | 1341.73 | 334.4 | 342.4 | 350.6 | |||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 1341.73 | 334.4 | 342.4 | 350.6 | |||||||||||||
balance-sheet.row.long-term-investments | -329.19 | 123.7 | -285.2 | -170.9 | |||||||||||||
balance-sheet.row.tax-assets | 749.62 | 0 | 0 | 268.3 | |||||||||||||
balance-sheet.row.other-non-current-assets | 41.6 | 9.7 | 401.1 | 19.3 | |||||||||||||
balance-sheet.row.total-non-current-assets | 13682.57 | 3414.6 | 3532.3 | 3472.8 | |||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.total-assets | 26299.62 | 6073.8 | 6569.1 | 6551.3 | |||||||||||||
balance-sheet.row.account-payables | 712.91 | 179.1 | 205.4 | 155.6 | |||||||||||||
balance-sheet.row.short-term-debt | 5054.62 | 1009.7 | 980.4 | 422.6 | |||||||||||||
balance-sheet.row.tax-payables | 5.73 | 1 | 1 | 0.7 | |||||||||||||
balance-sheet.row.long-term-debt-total | 5311.01 | 1074.5 | 1622.5 | 2330.7 | |||||||||||||
Deferred Revenue Non Current | 419.44 | 102.9 | 118.5 | 127.2 | |||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 1412.84 | - | - | - | |||||||||||||
balance-sheet.row.other-current-liab | 957.85 | 266.7 | 252.2 | 234.8 | |||||||||||||
balance-sheet.row.total-non-current-liabilities | 5628.08 | 1074.7 | 1741 | 2480.6 | |||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.capital-lease-obligations | 1.09 | 0.3 | 0.3 | 0.3 | |||||||||||||
balance-sheet.row.total-liab | 12374.33 | 2535.3 | 3184.5 | 3300.2 | |||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.common-stock | 1572.35 | 393.2 | 407.5 | 407.4 | |||||||||||||
balance-sheet.row.retained-earnings | 3952.76 | 958.9 | 931.5 | 819.4 | |||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 4352.73 | 60 | 26.1 | 27.3 | |||||||||||||
balance-sheet.row.other-total-stockholders-equity | 3931.64 | 2020.3 | 2016.6 | 1994.5 | |||||||||||||
balance-sheet.row.total-stockholders-equity | 13809.48 | 3432.5 | 3381.6 | 3248.6 | |||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 26299.62 | 6073.8 | 6569.1 | 6551.3 | |||||||||||||
balance-sheet.row.minority-interest | 12.9 | 3 | 3.1 | 2.5 | |||||||||||||
balance-sheet.row.total-equity | 13822.38 | 3435.5 | 3384.7 | 3251.1 | |||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 26299.62 | - | - | - | |||||||||||||
Total Investments | 940.82 | 408.7 | 84.3 | 92.5 | |||||||||||||
balance-sheet.row.total-debt | 10366.17 | 2084.4 | 2602.9 | 2753.3 | |||||||||||||
balance-sheet.row.net-debt | 4360.6 | 1045.9 | 1276.7 | 1158.1 |
Отчет за паричните потоци
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -3.78 | 159.6 | 158.9 | 54.3 | |||||||||||||
cash-flows.row.depreciation-and-amortization | 1.83 | 268.9 | 275.4 | 257.5 | |||||||||||||
cash-flows.row.deferred-income-tax | -0.12 | 0 | -10.9 | -28 | |||||||||||||
cash-flows.row.stock-based-compensation | 6.33 | 0 | 10.9 | 28 | |||||||||||||
cash-flows.row.change-in-working-capital | -5.6 | -11.7 | -77.9 | -788.6 | |||||||||||||
cash-flows.row.account-receivables | 20.69 | 20.7 | -35.7 | 2.5 | |||||||||||||
cash-flows.row.inventory | -26.29 | -26.3 | -85.4 | -912.1 | |||||||||||||
cash-flows.row.account-payables | 0 | -6.1 | 43.2 | 121 | |||||||||||||
cash-flows.row.other-working-capital | 0 | 0 | 0 | 0 | |||||||||||||
cash-flows.row.other-non-cash-items | 365.42 | 107.8 | 137.3 | 63.1 | |||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 363.36 | 0 | 0 | 0 | |||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -160.14 | -107 | -245.9 | -286.5 | |||||||||||||
cash-flows.row.acquisitions-net | 0.03 | 0 | 3 | 0.4 | |||||||||||||
cash-flows.row.purchases-of-investments | -400.01 | -400 | -1310 | -510 | |||||||||||||
cash-flows.row.sales-maturities-of-investments | 465.26 | 450 | 1172.5 | 959.4 | |||||||||||||
cash-flows.row.other-investing-activites | 0.01 | 0 | 0 | 0.7 | |||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -94.86 | -57 | -380.4 | 164.1 | |||||||||||||
cash-flows.row.debt-repayment | -1774.33 | -544.4 | -1520.6 | -680.8 | |||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||||
cash-flows.row.dividends-paid | -287.7 | -117.9 | -170.3 | -148.7 | |||||||||||||
cash-flows.row.other-financing-activites | 204.76 | -92.9 | 1323 | 1459.6 | |||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -751.36 | -755.2 | -367.9 | 630.1 | |||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | -15.26 | 0 | 0 | 0 | |||||||||||||
cash-flows.row.net-change-in-cash | -465.48 | -287.7 | -254.6 | 380.6 | |||||||||||||
cash-flows.row.cash-at-end-of-period | 6005.57 | 1038.5 | 1326.2 | 1580.8 | |||||||||||||
cash-flows.row.cash-at-beginning-of-period | 6471.05 | 1326.2 | 1580.8 | 1200.2 | |||||||||||||
cash-flows.row.operating-cash-flow | 363.36 | 524.5 | 493.7 | -413.7 | |||||||||||||
cash-flows.row.capital-expenditure | -160.14 | -107 | -245.9 | -286.5 | |||||||||||||
cash-flows.row.free-cash-flow | 203.21 | 417.5 | 247.8 | -700.2 |
Ред за отчет за приходите
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 1793.48 | 1928.1 | 1970.3 | 1556.1 | |||||||||||||
income-statement-row.row.cost-of-revenue | 1526.42 | 1500.6 | 1468.8 | 1268.2 | |||||||||||||
income-statement-row.row.gross-profit | 267.06 | 427.5 | 501.5 | 288 | |||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||
income-statement-row.row.research-development | 13.62 | - | - | - | |||||||||||||
income-statement-row.row.selling-general-administrative | 24.82 | - | - | - | |||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 155.32 | - | - | - | |||||||||||||
income-statement-row.row.other-expenses | -6.7 | 0.6 | 33.7 | 4.5 | |||||||||||||
income-statement-row.row.operating-expenses | 249.5 | 247.2 | 231 | 187.4 | |||||||||||||
income-statement-row.row.cost-and-expenses | 1775.91 | 1747.7 | 1699.8 | 1455.6 | |||||||||||||
income-statement-row.row.interest-income | 28.61 | 31.6 | 31 | 53.6 | |||||||||||||
income-statement-row.row.interest-expense | 86.99 | 83.6 | 90.5 | 80.9 | |||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 155.32 | - | - | - | |||||||||||||
income-statement-row.row.total-other-income-expensenet | -5.41 | -17.6 | -148.7 | -67.3 | |||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||
income-statement-row.row.other-operating-expenses | -6.7 | 0.6 | 33.7 | 4.5 | |||||||||||||
income-statement-row.row.total-operating-expenses | -5.41 | -17.6 | -148.7 | -67.3 | |||||||||||||
income-statement-row.row.interest-expense | 86.99 | 83.6 | 90.5 | 80.9 | |||||||||||||
income-statement-row.row.depreciation-and-amortization | 111.67 | 268.9 | 275.4 | 257.5 | |||||||||||||
income-statement-row.row.ebitda-caps | 126.03 | - | - | - | |||||||||||||
income-statement-row.row.operating-income | 1.59 | 180.4 | 307.6 | 121.6 | |||||||||||||
income-statement-row.row.income-before-tax | -3.82 | 162.8 | 158.9 | 54.3 | |||||||||||||
income-statement-row.row.income-tax-expense | -0.04 | 3.2 | 0 | 66.7 | |||||||||||||
income-statement-row.row.net-income | -3.78 | 159.6 | 158.4 | -12.4 |
Често задавани въпроси
Какво е Tianshui Zhongxing Bio-technology Co.,Ltd. (002772.SZ) общи активи?
Tianshui Zhongxing Bio-technology Co.,Ltd. (002772.SZ) общите активи са 6073765300.000.
Какъв е годишният приход на предприятието?
Годишните приходи са 963914006.000.
Какъв е маржът на печалбата на предприятието?
Маржът на печалбата на фирмата е 0.517.
Какъв е свободният паричен поток на компанията?
Свободният паричен поток е 0.517.
Какъв е маржът на нетната печалба на предприятието?
Маржът на нетната печалба е -0.002.
Какъв е общият приход на предприятието?
Общият приход е 0.001.
Каква е Tianshui Zhongxing Bio-technology Co.,Ltd. (002772.SZ) нетна печалба (нетен доход)?
Нетната печалба (нетният доход) е 159581340.000.
Какъв е общият дълг на фирмата?
Общият дълг е 2084417918.000.
Какъв е броят на оперативните разходи?
Оперативните разходи са 247154405.000.
Какъв е броят на паричните средства на фирмата?
Паричните средства на предприятието са 1550208973.000.